Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A case of anti-Js(b) in pregnancy was associated with unexpectedly severe haemolytic disease of the newborn, requiring urgent exchange transfusion. Clinical signs of fetal distress were evident at 35 weeks of gestation in a sixth pregnancy. A Js(b+) baby from a previous pregnancy had been unaffected. This case report illustrates the difficulties of predicting severity on the basis of anti-Js(b) titre, and highlights issues relating to the problems of using reconstituted frozen red cells from the rare red cell bank for exchange transfusion.

Original publication

DOI

10.1046/j.1423-0410.2001.00092.x

Type

Journal article

Journal

Vox Sang

Publication Date

2001

Volume

81

Pages

134 - 135

Keywords

Adult, Erythroblastosis, Fetal, Erythropoietin, Exchange Transfusion, Whole Blood, Female, Humans, Infant, Newborn, Kell Blood-Group System, Pregnancy, Pregnancy Complications, Recombinant Proteins